Figure 2From: Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysisGeneral and pathological outcomes of KIT mutation-positive subgroup versus KIT mutation-negative subgroup. (a) Age; (b) gender; (c) KIT expression; (d) cell type; (e) primary tumor site; (f) tumor size; and (g) mitotic count.Back to article page